Citation Impact
Citing Papers
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Perspectives of Phage Therapy in Non-bacterial Infections
2019
Staphylococcus aureus Small-Colony Variants Are Independently Associated With Worse Lung Disease in Children With Cystic Fibrosis
2013
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
2004
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
2019 Standout
Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients
2010
A Comparison of Bayesian Methods for Haplotype Reconstruction from Population Genotype Data
2003 Standout
Eradication of early Pseudomonas aeruginosa infection
2005
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients
2008
Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU
2007
Molecular mechanisms of antibiotic resistance
2014 Standout
DICER1 mutations in childhood cystic nephroma and its relationship to DICER1-renal sarcoma
2014
Novel immunologic classification of aspergillosis in adult cystic fibrosis
2013
Catabolic effect in premature infants with early dexamethasone treatment
1996
Cystic fibrosis
2016 Standout
Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections
2005 Standout
Effect of community-based newborn-care intervention package implemented through two service-delivery strategies in Sylhet district, Bangladesh: a cluster-randomised controlled trial
2008 Standout
Managing Cystic Fibrosis
2011
Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis
2009
Pharmacology for the gastrointestinal tract
2002
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
A randomised, double blind, placebo controlled trial of the effect of theophylline in prevention of vasomotor nephropathy in very preterm neonates with respiratory distress syndrome
2005
Retinopathy of prematurity
2013 Standout
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
2014 Standout
The Effectiveness of Mobile-Health Technology-Based Health Behaviour Change or Disease Management Interventions for Health Care Consumers: A Systematic Review
2013 Standout
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
2007 Standout
Postnatal steroids: Short-term gain, long-term pain?
2000
Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis
2012
Predicting the Functional Effect of Amino Acid Substitutions and Indels
2012 Standout
Aspergillus bronchitis without significant immunocompromise
2012
Determination of Extended-Interval Gentamicin Dosing for Neonatal Patients in Developing Countries
2007
Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic
2005
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Antibiotic Treatment of Multidrug-Resistant Organisms in Cystic Fibrosis
2003
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
Inhibitors of VIM-2 by screening pharmacologically active and click-chemistry compound libraries
2009 StandoutNobel
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
New pharmacological approaches for cystic fibrosis: Promises, progress, pitfalls
2014
Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa
2006
The Epidemiology of Pancreatitis and Pancreatic Cancer
2013 Standout
Homogenisation of cystic fibrosis sputum by sonication — An essential step for Aspergillus PCR
2011
Necrotizing Enterocolitis
2011 Standout
Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis
2015
Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing
2010
MicroRNA biogenesis pathways in cancer
2015 Standout
Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis
2011
European Cystic Fibrosis Society Standards of Care: Best Practice guidelines
2014
Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis
2012
The Etiology of Acute Recurrent Pancreatitis in Children
2011
Complete structural characterization of the lipid A fraction of a clinical strain of B. cepacia genomovar I lipopolysaccharide
2004
Cystic fibrosis genetics: from molecular understanding to clinical application
2014 Standout
Prospective evaluation of emerging bacteria in cystic fibrosis
2005
Early antibiotic treatment forPseudomonas aeruginosaeradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols
2012
Randomised controlled trial of an aggressive nutritional regimen in sick very low birthweight infants
1997
The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview
2011 Standout
Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis
2012
Colistin: an update on the antibiotic of the 21st century
2012
Call of the wild: antibiotic resistance genes in natural environments
2010 Standout
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
2016 Standout
Update on Key Emerging Challenges in Cystic Fibrosis
2014 Standout
Association of H2-Blocker Therapy and Higher Incidence of Necrotizing Enterocolitis in Very Low Birth Weight Infants
2006
Parenteral and Inhaled Colistin for Treatment of Ventilator-Associated Pneumonia
2006
Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial
2009
Adverse Effects of Early Dexamethasone Treatment in Extremely-Low-Birth-Weight Infants
2001
Antimicrobial resistance among gram-negative organisms in the intensive care unit
2003
Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa
2007
Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options
2015
Multi-Country Estimate of Different Manifestations of Aspergillosis in Cystic Fibrosis
2014
Reduced Bacterial Colony Count of Anaerobic Bacteria Is Associated with a Worsening in Lung Clearance Index and Inflammation in Cystic Fibrosis
2015
Stenotrophomonas maltophilia in Cystic Fibrosis
2010
Gut microbiota in human metabolic health and disease
2020 Standout
Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
2012
Antibody testing in aspergillosis—quo vadis?
2015
DICER1: mutations, microRNAs and mechanisms
2014
Bronchopulmonary Dysplasia
2001 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Lumacaftor/Ivacaftor in Patients Aged 6–11 Years with Cystic Fibrosis and Homozygous for F508del-CFTR
2017
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Factors Influencing Acquisition of Burkholderia cepacia Complex Organisms in Patients with Cystic Fibrosis
2013
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Tests for emotionality in rats and mice: A review
1973 Standout
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
Actinomyces and Related Organisms in Human Infections
2015 Standout
PmrB Mutations Promote Polymyxin Resistance of Pseudomonas aeruginosa Isolated from Colistin-Treated Cystic Fibrosis Patients
2011
The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis
2008
Serum Cortisol, Dehydroepiandrosterone Sulfate, and Steroid-Binding Globulins in Preterm Neonates: Effect of Gestational Age and Dexamethasone Therapy
1996
Polymyxin Resistance of Pseudomonas aeruginosa phoQ Mutants Is Dependent on Additional Two-Component Regulatory Systems
2013
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
PmrAB, a Two-Component Regulatory System of Pseudomonas aeruginosa That Modulates Resistance to Cationic Antimicrobial Peptides and Addition of Aminoarabinose to Lipid A
2003
Interventions for enhancing medication adherence
2014 Standout
Use of colistin in the treatment of multiple-drug-resistant gram-negative infections
2005
Burn Wound Infections
2006 Standout
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Clinical decision support systems for neonatal care
2005
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
PhoQ Mutations Promote Lipid A Modification and Polymyxin Resistance of Pseudomonas aeruginosa Found in Colistin-Treated Cystic Fibrosis Patients
2011
Lung Infections Associated with Cystic Fibrosis
2002 Standout
Arginine metabolism: nitric oxide and beyond
1998 Standout
Global Challenge of Multidrug-ResistantAcinetobacter baumannii
2007 Standout
Role of Excessive Inflammatory Response to Stenotrophomonas maltophilia Lung Infection in DBA/2 Mice and Implications for Cystic Fibrosis
2010
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Works of K. Brownlee being referenced
Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients
2003
Bilateral progressive cystic nephroma in a 9-month-old male infant requiring renal replacement therapy
2010
Aspergillus Bronchitis in Cystic Fibrosis
2006
An expert system to assist neonatal intensive care
1997
Lung clearance index: Evidence for use in clinical trials in cystic fibrosis
2013
Regimens for eradicating early Pseudomonas aeruginosa infection in children do not promote antibiotic resistance in this organism
2008
Alcaligenes infection in cystic fibrosis
2002
Adherence to nebulised therapies in adolescents with cystic fibrosis is best on week-days during school term-time
2013
Acute bronchopulmonary infection due to Streptococcus milleri in a child with cystic fibrosis
1999
‘Cepacia syndrome’ with Burkholderia multivorans, 9 years after initial colonization
2004
A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis
2008
Transmission of colistin‐resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center
2002
Serologic diagnosis of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis through the detection of immunoglobulin G to Aspergillus fumigatus
2008
Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center
2004
Gastric acid secretion in preterm infants
1993
Changes in the plasma aminogram of parenterally fed infants treated with dexamethasone for bronchopulmonary dysplasia.
1992
Early or late parenteral nutrition for the sick preterm infant?
1993
Catabolic effect of dexamethasone in the preterm baby.
1992
Plasma Creatinine Rises Dramatically in the First 48 Hours of Life in Preterm Infants
1999
Gastroduodenal perforation in preterm babies treated with dexamethasone for bronchopulmonary dysplasia.
1991
Adrenal response in very low birthweight babies after dexamethasone treatment for bronchopulmonary dysplasia.
1989